Overview
Dr. Stephan Rau advises investors, Healthcare service providers, pharmaceutical and MedTech companies, as well as governmental entities on M&A transactions, outsourcing projects, and licensing and reimbursement proceedings. He focuses his practice on mergers and acquisitions (M&A) transactions and regulatory advice in the Health and Life Science sector.
He is the head of the Firm’s Health Law Practice Group in Europe.
Stephan speaks regularly at Healthcare and Life Sciences industry as well as legal expert conferences, both at an international and national level. He is the author of numerous publications on German corporate law, Healthcare, and Life Sciences regulation. Prior to joining McDermott, he worked for international law firms in Moscow, Hamburg, and Berlin.
Results
Stephan advised:
- On investments in the clinical lab, renal care, hospital, pharma, medical device, biotech, food, and online pharmacy businesses
- On various outsourcing projects, such as joint ventures between one of the largest medical schools in Europe and a large public hospital carrier leading to the establishment of the largest European clinical lab
- Dialysis service providers on challenging market entry barriers under the German system of determination of need of the statutory health insurance system
- On disease management agreements with statutory health insurance funds
- On one of the largest public tenders for pharmaceuticals by the largest German public payer
- On compulsory early benefit assessments for new pharmaceutical products and related price negotiations under the Pharmaceuticals Market Reorganization Act (Arzneimittelmarkt-Neuordnungsgesetz (AMNOG)) proceedings
Recognitions
- Chambers Europe, Band 1, Germany: Healthcare, 2024
- Handelsblatt/Best Lawyers™, Germany: Biotechnology Law, Life Sciences Practice, Mergers and Acquisitions Law, Health Care Law and Pharmaceuticals Law, 2018-2024
- The Legal 500 EMEA, “Leading Individual” in Germany: Healthcare and Life Sciences, 2021-2024Show More
- JUVE Handbook of Commercial Law Firms, Recommended: Corporate, M&A, and Private Equity, and “Distinguished Advisor”: Health Services, 2022-2024
- Handelsblatt/Best Lawyers™, “Lawyer of the Year” in Germany: Biotechnology Law and Life Sciences Practice, 2023
- Chambers Europe, “Leading Individual”, since 2011 continuously ranked Band 1 for Healthcare, 2023
- Who’s Who Legal, “Global Elite Thought Leader”: Healthcare, 2022
- Handelsblatt/Best Lawyers™, “Leading Lawyer”in Germany: Mergers and Acquisitions Law and Pharmaceuticals Law, 2022
- Who’s Who Legal, Life Sciences and Healthcare, 2021
- Handelsblatt/Best Lawyers™, “Lawyer of the Year” in Germany: Pharmaceuticals Law, 2021
- Expert Guides, “Best of the Best” in Germany: Regulatory, Finance & Transactional, 2018-2019
- Leaders League’s Guide, Innovation, Technology & Patents: “Excellent” in the Health, Pharma & Biotechnology category, 2019
- Handelsblatt/Best Lawyers™, Recommended, Germany: Mergers & Acquisitions, 2019
- The Legal 500 EMEA, Recommended, Germany: Corporate M&A, 2017
- LMG Life Sciences: Life Science Star
Community
Credentials
Education
Humboldt University of Berlin, Dr. jur., 2003
Higher Court of Appeal, Berlin, Second State Exam, 1998
University of Heidelberg, First State Exam, 1996
University of Paris-Dauphine, Maîtrise en Économie Appliquée, 1994
London School of Economics and Political Science, Master of Science in Government, 1993
IHK Wiesbaden, interpreter and translator for Russian, 1990
